Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.leukres.2020.106493 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Very late-onset EBV-related cutaneous post-transplant lymphoproliferative disorder.
BMJ Case Rep
July 2025
Dermatology, Université de Liège Faculté de Médecine, Liège, Belgium.
The Epstein-Barr Virus-related cutaneous post-transplant lymphoproliferative disorder (EBV-cPTLD) is an exceptional complication of the immediate post-transplant period, related to the immunosuppression leading to EBV reactivation. EBV-cPTLD presents a heterogeneous dermatological spectrum complicating the diagnosis, hence requiring histology, immunohistochemistry (IHC) and in situ hybridisation (ISH) for confirmation.A woman in her 70s with a 24 year history of renal transplantation presented atypical infiltrated, hyperpigmented lesions on the left arm and leg along with general health deterioration.
View Article and Find Full Text PDFIntroduction: Artemis () deficiency causes radiosensitive severe combined immunodeficiency (SCID), although hypomorphic cases can manifest later-onset immunodeficiency, autoimmunity, or lymphoproliferation. We report a 45-year-old man with humoral immunodeficiency, opportunistic infections, and recurrent EBV-positive diffuse large B-cell lymphoma (DLBCL).
Methods: Genetic analysis was performed to identify mutations in the gene.
Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection: A case report.
Medicine (Baltimore)
March 2022
Division of Metabolism and Biosystemic Science, Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan.
Introduction: Posttransplant lymphoproliferative disease (PTLD) is a critical complication of hematopoietic stem cell transplantation (HSCT). PTLD is classified into early and late-onset PTLDs. In post-HSCT patients, late-onset PTLD is rare, particularly PTLD after HSCT for Epstein-Barr virus (EBV)-related lymphoproliferative disease.
View Article and Find Full Text PDFExpanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations.
J Clin Immunol
May 2021
Department of Translational Medical Sciences, Pediatrics Section, Federico II University of Naples, via S. Pansini 5, 80131, Naples, Italy.
Article Synopsis
- Human nude SCID is a genetic disorder causing immune deficiency, characterized primarily by a lack of thymus development (congenital athymia), hair loss (alopecia), and nail deformities (nail dystrophy), with only a few cases documented so far.
- Recent advancements in newborn screening and genetic sequencing have uncovered new cases and a range of immune system issues in patients with different mutation types in the FOXN1 gene.
- The study analyzed clinical data from 18 patients, revealing variations in symptoms and severity; many exhibited forms of severe immune deficiency, while some showed atypical phenotypes, suggesting that mutation type and residual gene function impact disease severity.